TAF15 amyloid filaments in frontotemporal lobar degeneration.
Journal
Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462
Informations de publication
Date de publication:
06 Dec 2023
06 Dec 2023
Historique:
received:
13
04
2023
accepted:
30
10
2023
pubmed:
7
12
2023
medline:
7
12
2023
entrez:
6
12
2023
Statut:
aheadofprint
Résumé
Frontotemporal lobar degeneration (FTLD) causes frontotemporal dementia (FTD), the most common form of dementia after Alzheimer's disease, and is often also associated with motor disorders
Identifiants
pubmed: 38057661
doi: 10.1038/s41586-023-06801-2
pii: 10.1038/s41586-023-06801-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s).
Références
Grossman, M. et al. Frontotemporal lobar degeneration. Nat. Rev. Dis. Primers 9, 40 (2023).
pubmed: 37563165
Neumann, M. & Mackenzie, I. R. A. Review: neuropathology of non-tau frontotemporal lobar degeneration. Neuropath. Appl. Neurobiol. 45, 19–40 (2019).
Shi, Y. et al. Structure-based classification of tauopathies. Nature 598, 359–363 (2021).
pubmed: 34588692
pmcid: 7611841
Arseni, D. et al. TDP-43 forms amyloid filaments with a distinct fold in type A FTLD-TDP. Nature 620, 898–903 (2023).
Arseni, D. et al. Structure of pathological TDP-43 filaments from ALS with FTLD. Nature 601, 139–143 (2022).
pubmed: 34880495
Borroni, B. et al. Mutation within TARDBP leads to frontotemporal dementia without motor neuron disease. Hum. Mutat. 30, E974–E983 (2009).
pubmed: 19655382
Kovacs, G. G. et al. TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea. Mov. Disord. 24, 1842–1847 (2009).
Hutton, M. et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702–705 (1998).
pubmed: 9641683
Poorkaj, P. et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol. 43, 815–825 (1998).
pubmed: 9629852
Spillantini, M. G. et al. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl Acad. Sci. USA 95, 7737–7741 (1998).
pubmed: 9636220
pmcid: 22742
Lashley, T., Rohrer, J. D., Mead, S. & Revesz, T. An update on clinical, genetic and pathological aspects of frontotemporal lobar degenerations. Neuropath. Appl. Neurobiol. 41, 858–881 (2015).
Neumann, M. et al. A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 132, 2922–2931 (2009).
pubmed: 19674978
pmcid: 2768659
Neumann, M. et al. Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease. Acta Neuropathol. 118, 605–616 (2009).
pubmed: 19669651
pmcid: 2864784
Munoz, D. G. et al. FUS pathology in basophilic inclusion body disease. Acta Neuropathol. 118, 617–627 (2009).
pubmed: 19830439
Lashley, T. et al. A comparative clinical, pathological, biochemical and genetic study of fused in sarcoma proteinopathies. Brain 134, 2548–2564 (2011).
pubmed: 21752791
pmcid: 3170529
Kwiatkowski, T. J. et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323, 1205–1208 (2009).
pubmed: 19251627
Vance, C. et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323, 1208–1211 (2009).
pubmed: 19251628
pmcid: 4516382
Murray, D. T. et al. Structure of FUS protein fibrils and its relevance to self-assembly and phase separation of low-complexity domains. Cell 171, 615–627 (2017).
pubmed: 28942918
pmcid: 5650524
Lee, M., Ghosh, U., Thurber, K. R., Kato, M. & Tycko, R. Molecular structure and interactions within amyloid-like fibrils formed by a low-complexity protein sequence from FUS. Nat. Commun. 11, 5735 (2020).
pubmed: 33184287
pmcid: 7665218
Sun, Y. et al. Molecular structure of an amyloid fibril formed by FUS low-complexity domain. iScience 25, 103701 (2022).
pubmed: 35036880
Langenhove, T. V. et al. Genetic contribution of FUS to frontotemporal lobar degeneration. Neurology 74, 366–371 (2010).
pubmed: 20124201
Snowden, J. S. et al. The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene. Acta Neuropathol. 122, 99–110 (2011).
pubmed: 21424531
Neumann, M. et al. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations. Brain 134, 2595–2609 (2011).
pubmed: 21856723
pmcid: 3170539
Brelstaff, J. et al. Transportin1: a marker of FTLD-FUS. Acta Neuropathol. 122, 591–600 (2011).
pubmed: 21847626
Neumann, M. et al. Transportin 1 accumulates specifically with FET proteins but no other transportin cargos in FTLD-FUS and is absent in FUS inclusions in ALS with FUS mutations. Acta Neuropathol. 124, 705–716 (2012).
pubmed: 22842875
Davidson, Y. S. et al. Nuclear carrier and RNA-binding proteins in frontotemporal lobar degeneration associated with fused in sarcoma (FUS) pathological changes. Neuropathol. Appl. Neurobiol. 39, 157–165 (2013).
pubmed: 22497712
pmcid: 3479345
Gami-Patel, P., Bandopadhyay, R., Brelstaff, J., Revesz, T. & Lashley, T. The presence of heterogeneous nuclear ribonucleoproteins in frontotemporal lobar degeneration with FUS-positive inclusions. Neurobiol. Aging 46, 192–203 (2016).
pubmed: 27500866
Schwartz, J. C., Cech, T. R. & Parker, R. R. Biochemical properties and biological functions of FET proteins. Annu. Rev. Biochem. 84, 355–379 (2015).
pubmed: 25494299
Couthouis, J. et al. A yeast functional screen predicts new candidate ALS disease genes. Proc. Natl Acad. Sci. USA 108, 20881–20890 (2011).
pubmed: 22065782
pmcid: 3248518
Couthouis, J. et al. Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. Hum. Mol. Genet. 21, 2899–2911 (2012).
pubmed: 22454397
pmcid: 3373238
Kwon, I. et al. Phosphorylation-regulated binding of RNA polymerase II to fibrous polymers of low-complexity domains. Cell 155, 1049–1060 (2013).
pubmed: 24267890
pmcid: 4010232
Chen, J. et al. The SGYS motif of TAF15 prion-like domain is critical to amyloid fibril formation. Biophys. J. 121, 2613–2623 (2022).
pubmed: 35643629
pmcid: 9300678
Lee, B. J. et al. Rules for nuclear localization sequence recognition by karyopherinβ2. Cell 126, 543–558 (2006).
pubmed: 16901787
pmcid: 3442361
Murray, K. A. et al. De novo designed protein inhibitors of amyloid aggregation and seeding. Proc. Natl Acad. Sci. USA 119, e2206240119 (2022).
pubmed: 35969734
pmcid: 9407671
Seidler, P. M. et al. Structure-based discovery of small molecules that disaggregate Alzheimer’s disease tissue derived tau fibrils in vitro. Nat. Commun. 13, 5451 (2022).
pubmed: 36114178
pmcid: 9481533
Schweighauser, M. et al. Structures of α-synuclein filaments from multiple system atrophy. Nature 585, 464–469 (2020).
pubmed: 32461689
pmcid: 7116528
Yang, Y. et al. Cryo-EM structures of amyloid-β 42 filaments from human brains. Science 375, 167–172 (2022).
pubmed: 35025654
pmcid: 7612234
Schweighauser, M. et al. Age-dependent formation of TMEM106B amyloid filaments in human brains. Nature 605, 310–314 (2022).
pubmed: 35344985
pmcid: 9095482
Chang, A. et al. Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases. Cell 185, 1346–1355 (2022).
pubmed: 35247328
pmcid: 9018563
Jiang, Y. X. et al. Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43. Nature 605, 304–309 (2022).
pubmed: 35344984
pmcid: 9844993
Perneel, J. et al. Accumulation of TMEM106B C-terminal fragments in neurodegenerative disease and aging. Acta Neuropathol. 145, 285–302 (2022).
pubmed: 36527486
Fan, Y. et al. Generic amyloid fibrillation of TMEM106B in patient with Parkinson’s disease dementia and normal elders. Cell Res. 32, 585–588 (2022).
pubmed: 35477998
pmcid: 9160068
Scheres, S. H. W. Amyloid structure determination in RELION-3.1. Acta Crystallogr. D Struct. Biol. 76, 94–101 (2020).
pubmed: 32038040
pmcid: 7008511
Jahn, T. R. et al. The common architecture of cross-β amyloid. J. Mol. Biol. 395, 717–727 (2010).
pubmed: 19781557
Scheres, S. H. W., Ryskeldi-Falcon, B. & Goedert, M. Molecular pathology of neurodegenerative diseases by cryo-EM of amyloids. Nature 621, 701–710 (2023).
pubmed: 37758888
Falcon, B. et al. Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules. Nature 568, 420–423 (2019).
pmcid: 6472968
Laferrière, F. et al. TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates. Nat. Neurosci. 22, 65–77 (2019).
pubmed: 30559480
Takeuchi, R. et al. Transportin 1 accumulates in FUS inclusions in adult-onset ALS without FUS mutation. Neuropath. Appl. Neurobiol. 39, 580–584 (2013).
Borrego-Écija, S. et al. Does ALS-FUS without FUS mutation represent ALS-FET? Report of three cases. Neuropathol. Appl. Neurobiol. 45, 421–426 (2019).
pubmed: 30375034
Ticozzi, N. et al. Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosis. Am. J. Med. Genet. B Neuropsychiatr. Genet. 156, 285–290 (2011).
Van Daele, S. H. et al. Genetic variability in sporadic amyotrophic lateral sclerosis. Brain 146, 3760–3769 (2023).
Dormann, D. et al. Arginine methylation next to the PY-NLS modulates transportin binding and nuclear import of FUS. EMBO J. 31, 4258–4275 (2012).
pubmed: 22968170
pmcid: 3501225
Mackenzie, I. R. A. et al. Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations. Acta Neuropathol. 117, 15–18 (2009).
pubmed: 19015862
Renton, A. E. et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72, 257–268 (2011).
pubmed: 21944779
pmcid: 3200438
Demichev, V., Messner, C. B., Vernardis, S. I., Lilley, K. S. & Ralser, M. DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput. Nat. Methods 17, 41–44 (2020).
pubmed: 31768060
Zivanov, J., Nakane, T. & Scheres, S. H. W. A Bayesian approach to beam-induced motion correction in cryo-EM single-particle analysis. IUCrJ 6, 5–17 (2019).
pubmed: 30713699
pmcid: 6327179
Rohou, A. & Grigorieff, N. CTFFIND4: fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 192, 216–221 (2015).
pubmed: 26278980
pmcid: 6760662
He, S. & Scheres, S. H. W. Helical reconstruction in RELION. J. Struct. Biol. 198, 163–176 (2017).
pubmed: 28193500
pmcid: 5479445
Kimanius, D., Dong, L., Sharov, G., Nakane, T. & Scheres, S. H. W. New tools for automated cryo-EM single-particle analysis in RELION-4.0. Biochem. J 478, 4169–4185 (2021).
pubmed: 34783343
Zivanov, J., Nakane, T. & Scheres, S. H. W. Estimation of high-order aberrations and anisotropic magnification from cryo-EM data sets in RELION-3.1. IUCrJ 7, 253–267 (2020).
pubmed: 32148853
pmcid: 7055373
Chen, S. et al. High-resolution noise substitution to measure overfitting and validate resolution in 3D structure determination by single particle electron cryomicroscopy. Ultramicroscopy 135, 24–35 (2013).
pubmed: 23872039
pmcid: 3834153
Casañal, A., Lohkamp, B. & Emsley, P. Current developments in Coot for macromolecular model building of electron cryo-microscopy and crystallographic data. Protein Sci. 29, 1055–1064 (2020).
Croll, T. I. ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps. Acta Crystallogr. D Struct. Biol. 74, 519–530 (2018).
pubmed: 29872003
pmcid: 6096486
Brown, A. et al. Tools for macromolecular model building and refinement into electron cryo-microscopy reconstructions. Acta Crystallogr. D Biol. Crystallogr. 71, 136–153 (2015).
pubmed: 25615868
pmcid: 4304694
Yamashita, K., Palmer, C. M., Burnley, T. & Murshudov, G. N. Cryo-EM single-particle structure refinement and map calculation using Servalcat. Acta Crystallogr. D Struct. Biol. 77, 1282–1291 (2021).
pubmed: 34605431
pmcid: 8489229
Williams, C. J. et al. MolProbity: more and better reference data for improved all-atom structure validation. Protein Sci. 27, 293–315 (2018).
pubmed: 29067766
Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70–82 (2021).
pubmed: 32881101